Review ArticleReviews and Contemporary Updates
The Role of Checkpoint Inhibition in Non–Small Cell Lung Cancer
Jonathan Lu and Robert A. Ramirez
Ochsner Journal December 2017, 17 (4) 379-387;
Jonathan Lu
1Department of Hematology and Oncology, Ochsner Clinic Foundation, New Orleans, LA
MBBSRobert A. Ramirez
1Department of Hematology and Oncology, Ochsner Clinic Foundation, New Orleans, LA
2The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA
DO, FACPREFERENCES
- 1.↵
- Rahib L,
- Smith BD,
- Aizenberg R,
- Rosenzweig AB,
- Fleshman JM,
- Matrisian LM
- 2.↵
- Du L,
- Herbst RS,
- Morgensztern D
- 3.↵
- Torre LA,
- Siegel RL,
- Jemal A
- 4.↵SEER Cancer Statistics Review, 1975-2014. National Cancer Institute Accessed August 30, 2017 https://seer.cancer.gov/csr/1975_2014/.
- 5.↵
- Alberg AJ,
- Ford JG,
- Samet JM;
- 6.↵
- El-Telbany A,
- Ma PC
- 7.↵
- Azzoli CG,
- Baker S Jr,.,
- Temin S,
- et al.
- 8.
- Souquet PJ,
- Chauvin F,
- Boissel JP,
- et al.
- 9.↵
- Pignon JP,
- Tribodet H,
- Scagliotti GV,
- et al.
- 10.↵
- 11.↵
- Guo L,
- Zhang H,
- Chen B
- 12.↵
- Kirkwood JM,
- Butterfield LH,
- Tarhini AA,
- Zarour H,
- Kalinski P,
- Ferrone S
- 13.↵
- Leite KR,
- Reis ST, Junior.
- 14.↵
- Engelhardt JJ,
- Sullivan TJ,
- Allison JP
- 15.↵
- Hodi FS,
- O'Day SJ,
- McDermott DF,
- et al.
- 16.↵
- Grigg C,
- Rizvi NA
- 17.↵
- Skov BG,
- Skov T
- 18.
- Stoy S,
- Rosen L,
- Murgu S
- 19.↵
- Roach C,
- Zhang N,
- Corigliano E,
- et al.
- 20.↵
- Teixidó C,
- González-Cao M,
- Karachaliou N,
- Rosell R
- 21.↵
- Topalian SL,
- Hodi FS,
- Brahmer JR,
- et al.
- 22.↵
- Borghaei H,
- Paz-Ares L,
- Horn L,
- et al.
- 23.↵
- Brahmer J,
- Reckamp KL,
- Baas P,
- et al.
- 24.↵
- Kazandjian D,
- Suzman DL,
- Blumenthal G,
- et al.
- 25.↵FDA Expands Approved Use of Opdivo in Advanced Lung Cancer. US Food and Drug Administration https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm466413.htm. Accessed August 30, 2017.
- 26.↵
- Carbone DP,
- Reck M,
- Paz-Ares L,
- et al.
- 27.↵
- Rizvi NA,
- Mazières J,
- Planchard D,
- et al.
- 28.↵Non-Small Cell Lung Cancer (Version 5.2017). National Comprehensive Cancer Network https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed August 30, 2017.
- 29.↵
- Sul J,
- Blumenthal GM,
- Jiang X,
- He K,
- Keegan P,
- Pazdur R
- 30.↵
- Garon EB,
- Rizvi NA,
- Hui R,
- et al.
- 31.↵
- Herbst RS,
- Baas P,
- Kim DW,
- et al.
- 32.↵
- 33.↵Pembrolizumab (Keytruda) Checkpoint Inhibitor. US Food and Drug Administration https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm526430.htm. Accessed August 30, 2017.
- 34.↵Pembrolizumab (Keytruda) 5-10-2017. US Food and Drug Administration https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm558048.htm. Accessed August 30, 2017.
- 35.↵
- Langer CJ,
- Gadgeel SM,
- Borghaei H,
- et al.
- 36.↵Atezolizumab (TECENTRIQ). US Food and Drug Administration https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm525780.htm. Accessed August 30, 2017.
- 37.↵
- Fehrenbacher L,
- Spira A,
- Ballinger M,
- et al.
- 38.↵
- Rittmeyer A,
- Barlesi F,
- Waterkamp D,
- et al.
- 39.↵
- Wolchok JD,
- Kluger H,
- Callahan MK,
- et al.
- 40.↵
- Carrizosa DR,
- Gold KA
- 41.↵
- Bustamante Alvarez JG,
- González-Cao M,
- Karachaliou N,
- et al.
- 42.↵
- Antonia SJ,
- López-Martin JA,
- Bendell J,
- et al.
In this issue
The Role of Checkpoint Inhibition in Non–Small Cell Lung Cancer
Jonathan Lu, Robert A. Ramirez
Ochsner Journal Dec 2017, 17 (4) 379-387;
Jump to section
Cited By...
- No citing articles found.